New drug duo shows promise against tough cancers
Disease control
Completed
This study tested a new drug (TJ004309) alone or with another drug (Toripalimab) in 225 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to find the safest and most effective dose, and to see if the combination could shrink tumors…
Phase: PHASE1, PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:27 UTC